Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dual mRNA co-delivery for in situ generation of phagocytosis-enhanced CAR macrophages augments hepatocellular carcinoma immunotherapy
Zhenmei Yang, Ying Liu, Kun Zhao, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 718-733
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Recent progress in mRNA cancer vaccines
Ruhui Yao, C. Xie, Xiaojun Xia
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 35
A new era of cancer immunotherapy: combining revolutionary technologies for enhanced CAR-M therapy
Na Li, Shinan Geng, Zhenzhen Dong, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 19
In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials
Shihong Nie, Yuyang Qin, Liyuan Ou, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 9
CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond
Jialin Lu, Yuqing Ma, Q. Quentin Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 8
Exploring CAR-macrophages in non-tumor diseases: Therapeutic potential beyond cancer
Yizhao Chen, Qianling Xin, Mengjuan Zhu, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Intraperitoneal programming of tailored CAR macrophages via mRNA-LNP to boost cancer immunotherapy
Sitao Xie, Kedan Gu, Ting Liang, et al.
Research Square (Research Square) (2025)
Open Access | Times Cited: 1
Chimeric antigen receptor therapy meets mRNA technology
Jiacai Wu, Weigang Wu, Boping Zhou, et al.
Trends in biotechnology (2023) Vol. 42, Iss. 2, pp. 228-240
Open Access | Times Cited: 21
Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders
Runxuan Chu, Yi Wang, Jianglong Kong, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 20, pp. 4759-4784
Closed Access | Times Cited: 7
Advancing CAR-based immunotherapies in solid tumors: CAR- macrophages and neutrophils
Yanling Liang, Qumiao Xu, Qianqian Gao
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy
Jiawen Huang, Qian Yang, Wen Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Synergically enhanced anti-tumor immunity of in vivo CAR by circRNA vaccine boosting
Yanyan Wang, Liangru Lin, Xinyue Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 5
CAR-macrophage: Breaking new ground in cellular immunotherapy
Ting Huang, Chenqi Bei, Zhenhua Hu, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 5
The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies
Shuairan Zhang, Dong Hang, Xiuli Jin, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025) Vol. 1871, Iss. 3, pp. 167676-167676
Closed Access
Applications of mRNA Delivery in Cancer Immunotherapy
Xiaoyu Pan, Yang-Wen-Qing Zhang, Caixia Dai, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3339-3361
Open Access
Macrophages as Targets in Hepatocellular Carcinoma Therapy
Y. Liu, Zhengwei Mao, Yuan Ding, et al.
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 6, pp. 780-790
Open Access | Times Cited: 4
Silencing of SIRPα enhances the antitumor efficacy of CAR-M in solid tumors
Han Zhang, Yi Huo, Wenjing Zheng, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1335-1349
Open Access | Times Cited: 4
Unlocking the potential of chimeric antigen receptor T cell engineering immunotherapy: Long road to achieve precise targeted therapy for hepatobiliary pancreatic cancers
Hongli Gao, Lianyue Qu, Mu Li, et al.
International Journal of Biological Macromolecules (2025) Vol. 297, pp. 139829-139829
Closed Access
Harnessing myeloid cells in cancer
Suyeon Park, Ekaterina Pylaeva, Vikas Bhuria, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
A comprehensive review on targeting diverse immune cells for anticancer therapy: beyond immune checkpoint inhibitors
Dequan Liu, Lei Liu, Xinming Zhao, et al.
Critical Reviews in Oncology/Hematology (2025) Vol. 210, pp. 104702-104702
Open Access
Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access
Looking back, moving forward: protein corona of lipid nanoparticles
Yue Gao, Yeqi Huang, Chuanyu Ren, et al.
Journal of Materials Chemistry B (2024) Vol. 12, Iss. 23, pp. 5573-5588
Closed Access | Times Cited: 3
Targeting the Heterogeneous Tumour-Associated Macrophages in Hepatocellular Carcinoma
Aloña Agirre‐Lizaso, Maider Huici-Izagirre, Josu Urretabizkaia-Garmendia, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4977-4977
Open Access | Times Cited: 7
Engineering macrophages and their derivatives: A new hope for antitumor therapy
Wei Fang, Haiyang Liu, Yuxiao Wang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 177, pp. 116925-116925
Open Access | Times Cited: 2
Emerging nanomedicine strategies for hepatocellular carcinoma therapy
Guo Chen, Jiayu Zhang, Xiaomeng Cai, et al.
iMetaOmics. (2024) Vol. 1, Iss. 1
Open Access | Times Cited: 2
Engineering CaP-Pickering emulsion for enhanced mRNA cancer vaccines via dual DC and NK activations
Sihua Wu, Yan Zhou, Naoki Asakawa, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 837-852
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top